KIT and intrahepatic cholangiocarcinoma: We further found that loss of miR-10b-5p in KIT+ β cells and ICC in Kit-mir-10b KO mice led to diabetes and GI dysmotility, revealing a novel miR-10b-KLF11-KIT pathway that regulates glucose homeostasis and GI motility [16].